Efficacy and safety of artesunate for patients with IgA nephropathy: a study protocol for a multicenter, double-blind, randomized, placebo-controlled trial

BACKGROUND: IgA nephropathy is the most common glomerular disease and is a common cause of progression to end-stage renal disease in patients with kidney diseases. Proteinuria levels are critical for the prognosis of patients with IgA nephropathy, but many patients are still unable to effectively co...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Qi, Wang, Zi, Lv, Jicheng, Liu, Lijun, Li, Hang, Sun, Weiwei, Huo, Yanhong, Guo, Yingbo, Shen, Cun, Li, Shichao, Chen, Zhenjie, Zhou, Jingwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9134594/
https://www.ncbi.nlm.nih.gov/pubmed/35614482
http://dx.doi.org/10.1186/s13063-022-06336-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9134594/
https://www.ncbi.nlm.nih.gov/pubmed/35614482
http://dx.doi.org/10.1186/s13063-022-06336-3

Ejemplares similares